Core Viewpoint - The transaction aims to expand and operate mobile oxygen therapy services, enhancing high-altitude oxygen therapy accessibility and improving the company's industry position and influence [1]. Group 1 - The company announced a decision to invest in a new company using its own funds, in collaboration with related parties Chengdu Luzi Technology Co., Ltd. and Haikou Runyang Gongying Enterprise Management Partnership (Limited Partnership) [3]. - The management team has been authorized to handle all matters related to the investment, including subsequent funding and signing all legal documents associated with the joint investment [3]. - Upon completion of the transaction, the joint venture will be included in the company's consolidated financial statements [3]. Group 2 - The transaction is expected to strengthen the company's competitive advantages, sustainable development capabilities, and core competencies while gradually expanding new productive forces [1].

Core Viewpoint - The company 瑞迈特 (301367) has announced a strategic investment in a joint venture aimed at expanding its mobile oxygen therapy business and enhancing high-altitude oxygen therapy services [1] Group 1: Investment Details - 瑞迈特 will invest using its own funds alongside related parties 成都洛子科技有限公司 and 海口润氧共赢企业管理合伙企业 (有限合伙) [1] - The company will hold a 67% stake in the joint venture [1] Group 2: Business Focus - The joint venture is dedicated to the development and operation of mobile oxygen therapy services [1] - The initiative aims to promote and improve high-altitude oxygen therapy services [1]